Lees-Rolfe Garth Insider Trades

Insider Trading History

Track insider trading activity for Lees-Rolfe Garth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$269k 95,834 shares
$2.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Financial Officer
Holding Value $149k 90,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 95,834 shares
$2.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Financial Officer
Holding Value $782k 470,861 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.78M 1,139,097 shares
$3.32
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Financial Officer
Holding Value $149k 90,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 90,000 shares
$2.16
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Apr 01, 2024 Sale
$12.6k 5,834 shares
$2.16
$1.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up